Summary
The effects of plasma and an aqueous plasma fraction from patients with premenstrual syndrome (PMS) and control subjects on the uptake of 5-hydroxytryptamine (5-HT) in washed human platelets and rat forebrain synaptosomes were studied. Pre- and postmenstrual samples of unextracted plasma from the control group significantly enhanced platelet uptake of 5-HT. In contrast, an aqueous fraction following extraction of the plasma with organic solvents caused a dose-dependent decrease of 5-HT uptake. Plasma obtained from patients with PMS caused less stimulation of 5-HT uptake compared to plasma from the control group. The aqueous fraction of premenstrual plasma from patients tended to inhibit 5-HT uptake to a greater extent than a similar plasma fraction from controls. The inhibition of 5-HT uptake was associated with an increase in Km. Aqueous plasma fractions from both groups also inhibited 5-HT uptake in brain synaptosomes. However, there were no significant differences between groups. The results of the platelet study suggest that there may be quantitative differences in the plasma concentration of endogenous factors that affect 5-HT uptake between patients with PMS and control subjects and that such differences may explain the previously reported alteration of platelet 5-HT uptake and content associated with PMS symptoms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abraham GE (1983) Nutritional factors in the etiology of premenstrual tension syndromes. J Reprod Med 28: 446–464
Abraham KI, Ieni JR, Meyerson LR (1987) Purification and properties of a human plasma modulator for the platelet tricyclic/serotonin transport complex. Biochim Biophys Acta 923: 8–21
Anderson GM, Stevenson JM, Cohen DJ (1987) Steady-state model for plasma free and platelet serotonin in man. Life Sci 41: 1777–1785
Angel I, Paul SM (1984) Inhibition of synaptosomal [3H]-5-hydroxytryptamine uptake by an endogenous factor(s) in human blood. FEBS Lett 171: 280–284
Angel I, Goldman ME, Skolnick P, Pisano JJ, Paul SM (1985) Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum. In: Lal H, La Bella F, Lane J (eds) Endocoids. Alan R Liss, New York, pp 457–464
Ashby CR, Carr LA, Cook CL, Steptoe MM, Franks DD (1988) Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome. Biol Psych 24: 225–233
Barbaccia ML, Karoum F, Costa E (1985) Characterization of the endocoid for imipramine recognition sites. In: Lal H, La Bella F, Lane J (eds) Endocoids. Alan R Liss, New York, pp 431–440
Blier P, De Montigny C (1983) Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 3: 1270–1278
Bliss CI (1967) Statistics in biology. McGraw-Hill, New York, pp 348–403
Blundell JE (1979) Serotonin and feeding. In: Essman WB (ed) Serotonin in health and disease: clinical applications. Spectrum, New York, pp 403–450
Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211–218
Brown GL, Goodwin FK, Bunney WE (1982) Human aggression and suicide: their relationship to neuropsychiatry diagnoses and serotonin metabolism. In: Ho BT, Schoolar JC, Usdin E (eds) Advances in biochemical psychopharmacology, vol 34. Raven Press, New York, pp 287–306
Brusov OS, Fomenko AM, Katasonov AB (1985) Human plasma inhibitors of platelet serotonin uptake and imipramine receptor binding: extraction and heterogeneity. Biol Psychiatry 20: 235–244
Dalton K (1984) The premenstrual syndrome. Year Book Medical Publishers, Chicago, pp 3–10
Dunlay J (1983) Premenstrual syndrome. J Fam Pract 17: 29–42
Faull KF, Holman RB, Elliott GR, Barchas JD (1982) Tryptolines: artifacts or reality. A new method of analysis using GC/MS. In: Beta-carbolines and tetrahydroisoquinolines. Alan R Liss, New York, pp 135–154
Gershon MD, Tamir H (1984) Serotonectin and the family of proteins that bind serotonin. Biochem Pharmacol 33: 3115–3118
Huttunen P, Spencer BA, Meyers RD (1985) Monoamine transmitter release induced by tetrahydro-β-carboline perfused in hippocampus of the unrestrained rat. Brain Res Bull 15: 215–220
Jouvet M (1969) Biogenic amines and the states of sleep. Science 163: 32–41
Kamal LA, Cloix JF, Devynck MA, Meyer P (1983) [3H]-Serotonin uptake in human blood platelets is reduced by oubain and endogenous digitalis-like inhibitors of Na+, K+-ATPase. Eur J Pharmacol 92: 167–168
Kari I, Peura P, Airakinsen MM (1979) Mass fragmentographic determination of tetrahydro-β-carboline in human blood platelets and plasma. Med Biol 57: 412–414
Kellar KJ, Elliott GR, Holman BR, Vernikos-Danellis J, Barchas J (1976) Tryptoline inhibition of serotonin uptake in rat forebrain homogenates. J Pharmacol Exp Ther 168: 619–625
Langer SZ, Lee CR, Segonzac A, Tateishi T, Esnaud H, Schoemaker H, Winblad B (1984) Possible endocrine role of the pineal gland for 6-methoxytetrahydro-β-carboline: a putative endogenous neuromodulator of the [3H]-imipramine recognition site. Eur J Pharmacol 102: 379–380
Langer SZ, Lee CR, Schoemaker H, Segonzac A, Esnaud H (1985) 5-Methoxytryptoline and close analogs as candidates for the endogenous ligand of the3H-imipramine recognition site. In: Lal H, Labella F, Lane J (eds) Endocoids. Alan R Liss, New York, pp 441–455
Lingjaerde O (1977) Platelet uptake and storage of serotonin. In: Essman WB (ed) Serotonin in health and disease, vol 4. Spectrum, New York, pp 139–199
Majerus PW, Baenzinger NL (1974) Isolation of human platelets and platelet surface membranes. In: Fleischer S, Packer L (eds) Methods in enzymology, vol 31. Academic Press, New York, pp 149–155
Meltzer HY, Arora RC, Baber R, Tricou BJ (1981) Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry 38: 1322–1326
Messing RB, Fisher LA, Phebus L, Lyltle LD (1976) Interaction of diet and drugs in the regulation of brain 5-hydroxyindoles and the response to painful electric shock. Life Sci 18: 307–314
O'Brien PMS (1985) The premenstrual syndrome: a review. J Reprod Med 30: 113–126
van Praag HM (1986) Affective disorders and aggressive disorders: evidence for a common biological mechanism. Suicide Life Threat Behav 16: 21–49
Rapkin AJ, Edelmuth E, Chang LC, Reading AE, McGuire MT, Su T (1987) Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 70: 533–537
Rehavi M, Ventrua I, Sarne Y (1985) Demonstration of endogenous “imipramine-like” material in rat brain. Life Sci 36: 687–693
Rommelspacher H, Strauss SM, Rehse K (1978) β-Carbolines: a tool for investigating structure-activity relationships of the high affinity uptake of serotonin, dopamine, GABA and choline into a synaptosome-rich fraction of various regions from rat brain. J Neurochem 30: 1573–1578
Skolnick P, Crawley JN, Glowa JR, Paul S (1984) Beta-carboline induced anxiety states. Psychopathology 17 [Suppl 3]: 52–60
Tamir H, Kupsky WJ, Huang YL, Gershon MD (1983) Serotonin-binding glycoprotein of rat platelets. J Cell Sci 62: 439–458
Tamir H, Payett RF, Huang YL, Liu KP, Gershon MD (1985) Human serotonectin: a blood glycoprotein that binds serotonin and is associated with platelets and white blood cells. J Cell Sci 73: 187–206
Taylor DL, Matthew RJ, Ho BT, Wienman ML (1984) Serotonin levels and platelet uptake during premenstrual tension. Neuropsychobiology 12: 16–18
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ashby, C.R., Carr, L.A., Cook, C.L. et al. Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome. J. Neural Transmission 79, 41–50 (1990). https://doi.org/10.1007/BF01250999
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01250999